Our editorial advisory board member Donna Hallas, , PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights an article published in the March issue of Contemporary Pediatrics. Many parents may be using at-home ...

Several data points for lebrikizumab (EBGLYSS; Lilly), a monoclonal antibody targeting interleukin-13, were reported at the 2025 American Academy of Dermatology (AAD) meeting held in Orlando, Florida ...

A 13-year-old female with a history of iron deficiency anemia presented with altered mental status preceded by 5 days of headache, vomiting, nausea, and worsening somnolence that was not responsive to ...

On March 26, 2025, the new drug application (NDA) for diazoxide choline extended-release tablets (VYKAT XR; Soleno Therapeutics) was approved by the FDA to treat hyperphagia among individuals aged 4 ...

Recent research detailed that a child was most likely to be killed in a mass shooting by a parent or family member vs a stranger or peer. Study investigator Stephanie Chao, MD, breaks down these data.

In the phase 1/2 INSPIRE DUCHENNE trial, data from the first 3 patients dosed revealed an average microdystrophin expression of 110%, as measured by western blot, and improvements in multiple ...

A new clinical trial has found that omalizumab (Xolair; Genetech, Novartis) is more effective than oral immunotherapy (OIT) in treating multi-food allergy in individuals with severe allergic reactions ...

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis. Welcome to this Contemporary Pediatrics poll. Take a look ...

In 2021, the American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry, and the Children’s Hospital Association jointly declared a national emergency in child and adolescent ...

The approval marks a vital step toward care for urinary tract infections, helping to reduce recurrence and improve patients’ quality of life. The FDA has approved gepotidacin (Blujepa; GSK), for use ...

Pediatric cancer survivors can be vulnerable to cardiovascular disease in the short- or long-term with increased recognition of cardiotoxic cancer treatments, as 5-year survival rates for children are ...

Tina Tan, MD, FIDSA, FPIDS, FAAP, comments on the FDA's recent selection of the 2025-2026 influenza vaccine compositions, without the CDC's ACIP meeting and FDA's VRBPAC meeting. On March 13, 2025, ...